Ex parte SRIVASTAVA - Page 8


            Appeal No. 1996-2009                                                      
            Application No. 07/982,193                                                



            expression vector for site-specific integration and cell-                 
            specific gene expression" as the claims require is                        
            unclear. The examiner does not explained why one would                    
            have expected the Izban promoter to predominate or                        
            otherwise disregard Lebkowski's p40.  Neither reference                   
            involves combining promoters, and neither discusses the                   
            consequences related to such a combination.                               
            Consequently, based on the information in these                           
            references, one can only speculate as to the result of                    
            the combination.  We agree with appellant's argument that                 
            "in the absence of the requisite teaching of the present                  
            invention there could not be a reasonable expectation                     
            that the inclusion of a cell-specific promoter such as                    
            that disclosed by Izban et al. in the vector of Lebkowski                 
            et al. can achieve the present invention, especially                      
            since the vectors of Lebkowski et al. contain a strong                    
            promoter capable of overriding a cell-specific promoter                   
            [appellant's emphasis]."  Brief, sentence bridging pp. 5-                 
            6.  The examiner has therefore not established that,                      
            based on the prior art disclosures, those of ordinary                     
            skill would have had a reasonable expectation of success                  
            in obtaining "an expression vector for site-specific                      
            integration and cell-specific gene expression."                           
            Accordingly, under this scenario, the examiner has not                    

                         8                                                            



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007